Hetero Biopharma Limited Rituximab Export Data — India (DGFT 2022–2026)

Name: Hetero Biopharma Limited Rituximab Export Records India — #5 Exporter, 8 Shipments, $400.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Rituximab

India Pharmaceutical Trade Intelligence

$19.1M164 Suppliers104 CountriesHS 30021500

ExportsIndia → RUSSIA47.2%India → SRI LANKA11.3%

ImportsGERMANY → India$4.0M SWITZERLAND → India$487.9K

#1 Buyer: JSC R-PHARM

Hetero Biopharma Limited — Rituximab Exporter #5 | $400.0K Trade Value | TransData Nexus | TransData Nexus

Hetero Biopharma Limited — Rituximab Exporter Profile

Indian Pharmaceutical Exporter · #5 for Rituximab · $400.0K export value · DGFT Verified

Hetero Biopharma Limited is the #5 Indian exporter of Rituximab with $400.0K in export value and 8 verified shipments. Hetero Biopharma Limited holds a 2.1% market share in Rituximab exports across 4 countries. The company exports 2 pharmaceutical products worth $600.0K across 1 therapeutic categories.

Hetero Biopharma Limited — Rituximab Export Profile: Buyers & Destinations

Hetero Biopharma Limited Rituximab export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Rituximab?

Country	Value	Shipments	Share
SRI LANKA	$1.5M	30	21.7%
MEXICO	$719.8K	37	10.4%
KENYA	$657.9K	211	9.5%
RUSSIA	$650.0K	13	9.4%

Who Are the Top Buyers of Rituximab from India?

Buyer	Country	Value	Orders
JSC R-PHARM	RUSSIA	$550.0K	11
ABC PHARMA SERVICES (PVT) LTD	SRI LANKA	$430.6K	10
DR.REDDYS LABORATORIES PHILIPPINES	PHILIPPINES	$368.9K	8
STATE PHARMACEUTICALS CORPORATION	SRI LANKA	$300.0K	6
LABORATORIOS LEGRAND S A	COLOMBIA	$250.0K	5
LABORATORIOS LEGRAND S.A	COLOMBIA	$250.0K	5
STATE PHARMACEUTICALS CORPORATION O	SRI LANKA	$150.0K	3
XXAROXXPHAXXA SXX DXXC V	MEXICO	$100.0K	2
DROGUERIA MK LAB S.A.C	PERU	$100.0K	2
SYNTEGON TECHNOLOGY GMBH	GERMANY	$100.0K	2

India's Rituximab is purchased by 292 buyers worldwide. The top buyer is JSC R-PHARM (RUSSIA), followed by ABC PHARMA SERVICES (PVT) LTD and DR.REDDYS LABORATORIES PHILIPPINES.

How Does Hetero Biopharma Limited Compare to Nearest Rituximab Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	DR.REDDY'S LABORATORIES LTD	$3.2M	64	17	$50.0K
3	DR REDDYS LABORATORIES LIMITED	$550.0K	11	5	$50.0K
5	HETERO BIOPHARMA LIMITED ★	$400.0K	8	4	$50.0K
4	MEDWISE OVERSEAS PRIVATE LIMITED	$250.0K	5	1	$50.0K
7	INTAS PHARMACEUTICALS LIMITED	$158.4K	13	4	$12.2K

Hetero Biopharma Limited ranks #5 among 164 Indian Rituximab exporters. Average shipment value of $50.0K compared to the market average of $57.4K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and DR REDDYS LABORATORIES LIMITED.

Which Indian Ports Ship Rituximab Exports?

Port	Shipments	% Share
SAHAR AIR	389	32.0%
SAHAR AIR CARGO ACC (INBOM4)	325	26.7%
Bombay Air	85	7.0%
Bombay Air Cargo	58	4.8%
HYDERABAD ACC (INHYD4)	46	3.8%
DELHI AIR CARGO ACC (INDEL4)	45	3.7%
DELHI AIR	35	2.9%
AHEMDABAD AIR	26	2.1%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Rituximab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Biopharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 104+ countries, 292+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Rituximab

Rituximab

Hetero Biopharma Limited — Rituximab Exporter Profile

Hetero Biopharma Limited — Rituximab Export Profile: Buyers & Destinations

Where Does India Export Rituximab?

Who Are the Top Buyers of Rituximab from India?

What Is India's Total Rituximab Export Value and How Much Does Hetero Biopharma Limited Contribute?

What Is the Average Shipment Value for Hetero Biopharma Limited's Rituximab Exports?

How Does Hetero Biopharma Limited Compare to Other Indian Rituximab Exporters?

Regulatory Requirements: Exporting Rituximab to Key Markets

Mexico — COFEPRIS

How Does Hetero Biopharma Limited Compare to Nearest Rituximab Exporters?

Which Indian Ports Ship Rituximab Exports?

What Other Advanced Oncology Products Does Hetero Biopharma Limited Export?

About Hetero Biopharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Rituximab Export Data from Hetero Biopharma Limited

Rituximab Stats

Company Overview

Top Products by Hetero Biopharma Limited

Related Analysis

Need Detailed Export Data?

Data Source